Asperger Syndrome Market Research Report - Forecast to 2027

Asperger Syndrome Market Research Report: By Diagnosis (DSM-IV, Differential Diagnosis, GADS, KADI, Childhood Asperger Syndrome Test), by Treatment (Speech-Language Therapy, Occupational Therapy, Medication), and by End-User – Global Forecast Till 2027

ID: MRFR/Pharma/4383-HCR | February 2021 | Region: Global | 100 pages

Please note that the assessment period of report has been updated from 2017-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


The Asperger syndrome is a type of developmental disorders known as Autistic Spectrum Disorder (ASD). These disorders initiate in childhood and stay with individuals until their adult life. Children with the Asperger syndrome function better than those with autism, and they have normal intelligence and language development. Although they may develop problems while communicating as they get older. Some of the common symptoms of the Asperger syndrome include repetitive behaviors, unusual preoccupations or rituals, limited range of interests, problems with social skills, communication difficulties, and coordination problems.


According to the statistics suggested by the World Health Organization (WHO), around 1 in 160 children are dealing with Autism Spectrum Disorder (ASD). Evidence-based psychosocial interventions, such as parent skills training programs and behavioral treatments can reduce difficulties in communication and social behavior in ASD patients.


It is noted that increasing technological advancements, government-sponsored awareness programs for autism, and the increasing prevalence of autism and related complications are the key factors driving the Asperger syndrome market.


Various other factors such as the growing awareness of autistic spectrum disorder, increasing patient pool, unmet medical needs, enhancing regulatory framework, increasing government assistance, and rising funding and reimbursement are continuously contributing to the growth of the global Asperger syndrome market.


Despite these drivers, there are some setbacks associated with the Asperger syndrome market. The side-effects associated with the drugs, strict FDA regulations, and poor healthcare system in low- and middle-income countries may hinder the growth of the market to a considerable extent.


It is estimated that the Asperger syndrome market is expected to grow at a CAGR 6.0% during the forecast period of 2017–2023.


Research Methodology


 Asperger Syndrome Market


Sources: Annual reports, Press release, White paper, and Company presentation


Intended Audience



  • Pharmaceutical Companies

  • Research and Development (R&D) Companies

  • Diagnostic Laboratories

  • Government Research Institutes

  • Academic Institutes and Universities


Segmentation


The global Asperger syndrome market is segmented by diagnosis, treatment, and end-user.


By diagnosis, the market is classified as DSM-IV, differential diagnosis, childhood Asperger syndrome test, Gilliam Asperger's Disorder Scale (GADS), Krug Asperger's Disorder Index (KADI), and others. The differential diagnosis is further classified as schizophrenia spectrum, personality disorder, nonverbal learning disorder, social anxiety disorder, Tourette syndrome, obsessive-compulsive disorder, major depressive disorder, pragmatic semantic disorder, stereotypic movement disorder, bipolar disorder, and others.


By treatment, the market is classified as parent education and training, social skills training, speech-language therapy, Applied Behavioral Analysis (ABA), sensory integration/occupational therapy, and medication. The medication segment is further classified as antipsychotics, selective serotonin reuptake inhibitors, psychiatric agents, and others. Antipsychotics include risperidone, paliperidone, and aripiprazole. The selective serotonin reuptake inhibitors include fluvoxamine, fluoxetine, sertraline, paroxetine, citalopram, and escitalopram. The psychiatric agents include atomoxetine and guanfacine.


On the basis of end-user, the market is segmented into hospitals, clinics, diagnostic centers, drug stores, pharmacies, and others.


Regional Analysis


The Americas dominates the Asperger syndrome market owing to the increasing occurrence of autism spectrum disorders and related complications in this region and high healthcare expenditure. According to the data suggested by the Autism Society, more than 3.5 million Americans are living with an autism spectrum disorder.


On considering the historical data, it is found that from the year 2000 to 2010, the prevalence of autism in the Americans has increased by 119.4 %, i.e., 1 in 150 to 1 in 68. It is also reported that in the U.S., Autism services cost around USD 236-262 billion annually, out of which, the majority of the costs is covered in adult services, i.e., USD 175–196 billion compared to USD 61–66 billion for children.


Europe holds the second position in the Asperger syndrome market. The government support towards research and development and amendments in reimbursement policies in healthcare are expected to drive the European Asperger syndrome market.


According to the Autism Society, around 1 in 100 people in the U.K. are expected to have an autistic spectrum disorder.


Asia Pacific is the fastest growing Asperger syndrome market owing to a huge patient pool and development in the pharmaceutical sector. Healthcare expenditure is found to be boosting in various regions of Asia Pacific. As per the data suggested by the Australian Institute of Health and Welfare during the year 2015–16, the total health expenditure was nearly USD 170.4 billion, i.e., 3.6% higher than the expenditure of 2014–2015.


The Middle East and Africa holds the lowest share of the global market due to slow development, lack of technical knowledge, and poor medical facilities.


Key Players


Some of the key players in the global Asperger syndrome market are Eli Lilly and Company's, Shire, Jazz Pharmaceuticals, Pfizer, GlaxoSmithKline, Forest Laboratories, Inc., Johnson and Johnson, Bristol-Myers Squibb, Otsuka Pharmaceutical Company, Ltd., Johnson & Johnson Services, Inc., AstraZeneca, Allergan, Inc., and others.



Frequently Asked Questions (FAQ) :


Asperger syndrome is a developmental disorder characterized by repetitive behaviors, unusual preoccupations or rituals, limited range of interests, problems with social skills, communication difficulties, and coordination problems.

Asperger Syndrome Market is expected to exhibit a strong 6% CAGR over the forecast period from 2020 to 2027.

Growing awareness about autism spectrum disorders is the major driver for the Asperger Syndrome Market.

Americas dominate the Global Asperger Syndrome Market due to growing awareness about developmental disorders in the region.

Leading players in the Asperger Syndrome Market include Eli Lilly, Bristol-Myers Squibb, and Shire, among others.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Asperger Syndrome Market, by Diagnosis

6.1 Introduction

6.2 DSM-IV

6.2.1 Market Estimates & Forecast, 2020–2027

6.3 Differential Diagnosis

6.3.1 Market Estimates & Forecast, 2020–2027

6.4 Childhood Asperger Syndrome Test

6.4.1 Market Estimates & Forecast, 2020–2027

6.5 Gilliam Asperger's Disorder Scale (GADS)

6.5.1 Market Estimates & Forecast, 2020–2027

6.6 Krug Asperger's Disorder Index (KADI)

6.6.1 Market Estimates & Forecast, 2020–2027

6.7 Others

6.7.1 Market Estimates & Forecast, 2020–2027

Chapter 7. Global Asperger Syndrome Market, by treatment

7.1 Introduction

7.2 Parent Education & Training

7.2.1 Market Estimates & Forecast, 2020–2027

7.3 Social Skills Training

7.3.1 Market Estimates & Forecast, 2020–2027

7.4 Speech-Language Therapy

7.4.1 Market Estimates & Forecast, 2020–2027

7.5 Applied Behavioral Analysis (ABA)

7.5.1 Market Estimates & Forecast, 2020–2027

7.6 Medication

7.6.1 Market Estimates & Forecast, 2020–2027

Chapter 8. Global Asperger Syndrome Market, by End-User

8.1 Introduction

8.2 Hospitals

8.2.1 Market Estimates & Forecast, 2020–2027

8.3 Clinics

8.3.1 Market Estimates & Forecast, 2020–2027

8.4 Diagnostic Centers

8.4.1 Market Estimates & Forecast, 2020–2027

8.5 Drug Stores

8.5.1 Market Estimates & Forecast, 2020–2027

8.6 Pharmacies

8.6.1 Market Estimates & Forecast, 2020–2027

8.7 Others

8.7.1 Market Estimates & Forecast, 2020–2027

Chapter 9. Global Asperger Syndrome Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.1 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 U.K.

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest of the Middle East & Africa

Chapter 10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

Chapter 11 Company Profiles

11.1 Eli Lilly and Company’s

11.1.1 Company Overview

11.1.2 Types Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Shire

11.2.1 Company Overview

11.2.2 Types Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Jazz Pharmaceuticals

11.3.1 Company Overview

11.3.2 Types Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Pfizer

11.4.1 Company Overview

11.4.2 Types/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 GlaxoSmithKline

11.5.1 Company Overview

11.5.2 Types Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 Forest Laboratories, Inc.

11.6.1 Company Overview

11.6.2 Types Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.7 JOHNSON & JOHNSON SERVICES, INC.

11.7.1 Overview

11.7.2 Types Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Asperger Syndrome industry

Chapter 13 Appendix

LIST OF TABLES

Table 1 Asperger Syndrome Industry Synopsis, 2020–2027

Table 2 Asperger Syndrome Market Estimates & Forecast, 2020–2027, (USD Million)

Table 3 Asperger Syndrome Market, by Region, 2020–2027, (USD Million)

Table 4 Asperger Syndrome Market, by Diagnosis, 2020–2027, (USD Million)

Table 5 Asperger Syndrome Market, by Treatment, 2020–2027, (USD Million)

Table 6 Asperger Syndrome Market, by End-User, 2020–2027, (USD Million)

Table 7 North America Asperger Syndrome Market, by Diagnosis, 2020–2027, (USD Million)

Table 8 North America Asperger Syndrome Market, by Treatment, 2020–2027, (USD Million)

Table 9 North America Asperger Syndrome Market, by End-User, 2020–2027, (USD Million)

Table 10 U.S. Asperger Syndrome Market, by Diagnosis, 2020–2027, (USD Million)

Table 11 U.S. Asperger Syndrome Market, by Treatment, 2020–2027, (USD Million)

Table 12 U.S. Asperger Syndrome Market, by End-User, 2020–2027, (USD Million)

Table 13 Canada Asperger Syndrome Market, by Diagnosis, 2020–2027, (USD Million)

Table 14 Canada Asperger Syndrome Market, by Treatment, 2020–2027, (USD Million)

Table 15 Canada Asperger Syndrome Market, by End-User, 2020–2027, (USD Million)

Table 16 South America Asperger Syndrome Market, by Diagnosis, 2020–2027, (USD Million)

Table 17 South America Asperger Syndrome Market, by Treatment, 2020–2027, (USD Million)

Table 18 South America Asperger Syndrome Market, by End-User, 2020–2027, (USD Million)

Table 19 Europe Asperger Syndrome Market, by Diagnosis, 2020–2027, (USD Million)

Table 20 Europe Asperger Syndrome Market, by Treatment, 2020–2027, (USD Million)

Table 21 Europe Asperger Syndrome Market, by End-User, 2020–2027, (USD Million)

Table 22 Western Europe Asperger Syndrome Market, by Diagnosis, 2020–2027, (USD Million)

Table 23 Western Europe Asperger Syndrome Market, by Treatment, 2020–2027, (USD Million)

Table 24 Western Europe Asperger Syndrome Market, by End-User, 2020–2027, (USD Million)

Table 25 Eastern Europe Asperger Syndrome Market, by Diagnosis, 2020–2027, (USD Million)

Table 26 Eastern Europe Asperger Syndrome Market, by Treatment, 2020–2027, (USD Million)

Table 27 Eastern Europe Asperger Syndrome Market, by End-User, 2020–2027, (USD Million)

Table 28 Asia Pacific Asperger Syndrome Market, by Diagnosis, 2020–2027, (USD Million)

Table 29 Asia Pacific Asperger Syndrome Market, by Treatment, 2020–2027, (USD Million)

Table 30 Asia Pacific Asperger Syndrome Market, by End-User, 2020–2027, (USD Million)

Table 31 The Middle East & Africa Asperger Syndrome Market, by Diagnosis, 2020–2027, (USD Million)

Table 32 The Middle East & Africa Asperger Syndrome Market, by Treatment, 2020–2027, (USD Million)

Table 33 The Middle East & Africa Asperger Syndrome Market, by End-User, 2020–2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for the Asperger Syndrome Market

Figure 3 Segmentation Market Dynamics for the Asperger Syndrome Market

Figure 4 Global Asperger Syndrome Market Share, by Diagnosis, 2020

Figure 5 Global Asperger Syndrome Market Share, by Treatment, 2020

Figure 6 Global Asperger Syndrome Market Share, by End-User, 2020

Figure 7 Global Asperger Syndrome Market Share, by Region, 2020

Figure 8 North America Asperger Syndrome Market Share, by Country, 2020

Figure 9 Europe Asperger Syndrome Market Share, by Country, 2020

Figure 10 Asia Pacific Asperger Syndrome Market Share, by Country, 2020

Figure 11 Middle East & Africa Asperger Syndrome Market Share, by Country, 2020

Figure 12 Global Asperger Syndrome Market: Company Share Analysis, 2020 (%)

Figure 13 Eli Lilly and Company’s: Key Financials

Figure 14 Eli Lilly and Company’s: Segmental Revenue

Figure 15 Eli Lilly and Company’s: Geographical Revenue

Figure 16 Shire: Key Financials

Figure 17 Shire: Segmental Revenue

Figure 18 Shire: Geographical Revenue

Figure 19 Jazz Pharmaceuticals: Key Financials

Figure 20 Jazz Pharmaceuticals: Segmental Revenue

Figure 21 Jazz Pharmaceuticals: Geographical Revenue

Figure 22 Pfizer: Key Financials

Figure 23 Pfizer: Segmental Revenue

Figure 24 Pfizer: Geographical Revenue

Figure 25 GLAXOSMITHKLINE: Key Financials

Figure 26 GLAXOSMITHKLINE: Segmental Revenue

Figure 27 GlaxoSmithKline Geographical Revenue

Figure 28 Forest Laboratories, Inc.: Key Financials

Figure 29 Forest Laboratories, Inc.: Segmental Revenue

Figure 30 Forest Laboratories, Inc.: Geographical Revenue

Figure 31 JOHNSON & JOHNSON SERVICES, INC.: Key Financials

Figure 32 JOHNSON & JOHNSON SERVICES, INC.: Segmental Revenue

Figure 33 JOHNSON & JOHNSON SERVICES, INC.: Geographical Revenue